Form 4: DocuSign Exec Sells Shares Under 10b5-1 Plan
Insider Transaction Report
DocuSign's President General Manager of Growth, Robert Chatwani, reported sales of common stock and vesting of equity awards as part of a pre-arranged trading plan.
Summary
- Robert Chatwani, President General Manager of Growth at DocuSign, reported multiple transactions involving company common stock and derivative securities.
- On December 15, 2025, Chatwani sold 1,683 shares of common stock at $70.87 per share.
- On December 15, 2025, 31,538 shares of common stock were acquired at $0, likely due to the vesting of equity awards.
- On December 15, 2025, 16,019 shares were disposed of at $0 to satisfy tax obligations related to RSU and PSU vesting.
- On December 17, 2025, Chatwani sold 5,253 shares of common stock at prices ranging from $67.31 to $68.29.
- On December 17, 2025, an additional 8,565 shares of common stock were sold at prices ranging from $68.33 to $69.05.
- All sales were conducted pursuant to a Rule 10b5-1 plan.
- Various Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) vested on December 15, 2025, converting into common stock.
- Following these transactions, Chatwani beneficially owns 70,197 shares of DocuSign common stock.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions, including sales under a 10b5-1 plan and vesting of equity awards. This is generally neutral, as it reflects pre-planned liquidity management and compensation rather than a strong positive or negative signal about the company's immediate prospects.
Positives
- The vesting of a significant number of RSUs and PSUs indicates the executive is meeting service requirements and potentially performance targets.
- The transactions were executed under a Rule 10b5-1 plan, suggesting pre-planned sales rather than reactive selling based on new, non-public information.
Negatives
- Sales of common stock by an insider, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, indicating a reduction in direct equity exposure.
Future Outlook
The vesting schedules for Performance Stock Units (PSUs) extend through FY25, indicating future performance targets related to company subscription revenue and free cash flow will influence executive compensation.
Industry Context
These transactions reflect routine equity compensation and liquidity management for a senior executive at a technology company. The use of a 10b5-1 plan is a standard practice in the industry to manage insider stock sales in compliance with SEC regulations, mitigating concerns about trading on non-public information.
Comparison to Industry Standards
- The structure of equity compensation, including RSUs and PSUs with performance-based vesting tied to metrics like subscription revenue and free cash flow, aligns with common practices in the software and SaaS industry for executive incentives.
- The use of a 10b5-1 plan for stock sales is also a standard corporate governance practice among publicly traded companies to ensure compliance and transparency.
Related Party Transactions
- Robert Chatwani, an officer of DocuSign, engaged in transactions involving the company's common stock and derivative securities, which are inherently related-party transactions.
Stakeholder Impact
- Shareholders: The sales represent a slight reduction in the executive's direct ownership, but the overall beneficial ownership remains substantial. The 10b5-1 plan mitigates concerns about opportunistic selling.
- Employees: The vesting of equity awards is a standard part of executive compensation, which can be a positive signal for employee retention and motivation.
Next Steps
- Continued vesting of RSUs and PSUs for Robert Chatwani based on service and company performance metrics.
- Potential future sales or acquisitions by the reporting person as per the 10b5-1 plan or other personal financial planning.
Key Dates
| Date | Description |
|---|---|
| 2023-03-10 | Vesting commencement date for certain Restricted Stock Units (RSUs). |
| 2024-01-31 | End of FY24 Performance Period for certain Performance Stock Units (PSUs) based on subscription revenue and free cash flow. |
| 2024-05-10 | Vesting commencement date for certain Restricted Stock Units (RSUs). |
| 2025-01-31 | End of FY25 Performance Period for certain Performance Stock Units (PSUs) based on subscription revenue and free cash flow. |
| 2025-05-10 | Vesting commencement date for certain Restricted Stock Units (RSUs). |
| 2025-12-15 | Transaction date for sales of common stock, acquisition of common stock from vesting, disposition for tax obligations, and vesting of derivative securities. |
| 2025-12-17 | Transaction date for sales of common stock and signature date of the filing. |
Recommendation
holdThis Form 4 filing details routine insider transactions, including sales under a pre-arranged 10b5-1 plan and the vesting of equity compensation. Such transactions are generally neutral and do not typically provide a strong signal for a 'buy' or 'sell' recommendation. The executive continues to hold a significant number of shares and derivative securities, indicating continued alignment with shareholder interests. Therefore, a 'hold' recommendation is appropriate as this filing does not present new information that would fundamentally alter the investment thesis.
Keywords
DocuSign, DOCU, Form 4, Insider Trading, Robert Chatwani, Stock Sale, RSU Vesting, PSU Vesting, 10b5-1 Plan, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.